From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
The peptide effectively counters neuronal damage, including axonal and neuronal necrosis, which are critical factors in functional recovery
Discussing your medications and supplements with your healthcare provider is crucial
The effects of DSIP appear to persist beyond the single night of administration for some individuals, potentially allowing less frequent dosing while maintaining benefits
Some trials experimented with doses up to 50 mg per day